A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

Clinical trial NCT06206720 · COMPLETED

Trial details

NCT number: NCT06206720
Sponsor: Vigonvita Life Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infection

Start date: 2024-01-31
Primary completion: 2025-06-16
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.